RT Journal Article
SR Electronic
T1 The HR Challenges: Building Workplace Resilience in the Healthcare Industry During the COVID-19 Pandemic- A Systematic Review
JF medRxiv
FD Cold Spring Harbor Laboratory Press
SP 2022.02.03.22270380
DO 10.1101/2022.02.03.22270380
A1 Ajit Kerketta
A1 A N Raghavendra
YR 2022
UL http://medrxiv.org/content/early/2022/02/04/2022.02.03.22270380.abstract
AB The COVID-19 outbreak has wreaked havoc worldwide,disrupting industries and life, posing hitches for stakeholders, organizations, and common people. The viable workplace and smooth living have been challenged and forced the organizations to introduce an innovative, imaginative, and comprehensive approach to respond to the challenges. The companies have been striving hard to adjust to the new normal. At the same time, the government, on the other hand, is trying to normalize the situation for the general public.Industries have maintained their services by implementing a work-from-home strategy. However, forthe healthcare industry, it was not an option. Though telemedicine/consultation was hailed as a solution, but in low-income countries, it was met with skepticism, forcing health personnel to contact patients personally. However, this has jeopardized health workers’ lives and resulted in a human resource shortage.Nevertheless, the study aimed to identify HR challenges and interventionsto createa resilient workplace.Nonetheless, following a systematic review from17 databases, the HR challenges and strategic responses for a workable workplace have been highlighted. The results identified are shown in the table enlisting as challenges, manifestation, strategy, and different levels of the interventions. Furthermore, HR professionals devised a plan for the employees to rejuvenate and refresh themselves from stress and weariness by doing meditation yoga sessions that gave physical and mental support.All of these techniques contributed significantly to a stable working environment.Competing Interest StatementThe authors have declared no competing interest.Funding StatementNO. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.Not ApplicableThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:N/AI confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.Not ApplicableI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).Not ApplicableI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.Not ApplicableThis text is appropriate if the data are owned by a third party and authors do not have permission to share the data.